“…Based on the relationship with codified hormone-related syndromes, circulating markers of NEN are differentiated in common or broad spectrum, including chromogranin A (CgA), pancreatic polypeptide and neuron-specific enolase, and specific or individual, including serotonin and its metabolite 5-hydroxyindolylacetic acid, gastrin, glucagon, insulin, C-peptide, vasoactive intestinal peptide, somatostatin, histamine, calcitonin, parathyroid, somatotropic, adrenocorticotropic hormones, catecholamines and their metabolites and neuropeptides (Ferolla et al 2008). The present review is focused on CgA, a hydrophilic glycoprotein abundantly expressed in large dense core vesicles of neuroendocrine cells, whose main biological role is to regulate calcium-mediated exocytosis (Borges et al 2010). Consistent with the definition of a common marker, elevated levels of circulating CgA have been associated with almost all types of NEN, including those arising from the gastroenteropancreatic tract and the bronchopulmonary area, which represent the majority, but also pheocromocytomas/paragangliomas, medullary thyroid carcinoma, Merkel cell carcinoma of the skin and (even if data are controversial) pituitary and parathyroid adenomas (Sobol et al 1986, Blind et al 1992, Kimura et al 1997, Nobels et al 1997, Guignat et al 2001, Tomassetti et al 2001b, Campana et al 2007, Zatelli et al 2007).…”